About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Massachusetts | 508 Studies

Clinical Trials Prostate CancerMassachusetts

Prostate Cancer Clinical Trials in Massachusetts

Find 508 clinical trials for prostate cancer near Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 508 trials

CompletedS1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapyRATIONALE: Androgens can cause the growth of prostate cancer cells. Antiandrogen drugs, such as abiraterone acetate, may lessen the amount of androgens made by the body.NCT01309672·Jonesboro, Arkansas and 204 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingClinical Trial of Approaches to Prostate Cancer SurgeryThis is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus…NCT05155501·Duarte, California and 8 others

CompletedA Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active SurveillanceThe primary purpose of this study was to compare the time to prostate cancer progression (pathological or therapeutic progression) between patients treated with enzalutamide…NCT02799745·Birmingham, Alabama and 53 others

Active not recruitingDarolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the ProstateThe purpose of this study is to determine the effectiveness of darolutamide as part of adjuvant androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone…NCT04136353·Boston, Massachusetts and 92 others

TerminatedDose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate CancerThis study aims to evaluate the combination of GSK525762 with other agents that have been shown to be effective in the treatment of CRPC or metastatic (m)CRPC.NCT03150056·Los Angeles, California and 19 others

CompletedA Selective Androgen Receptor Modulator for Symptom Management in Prostate CancerThis research study is studying the use of a targeted therapy called LY SARM, which is an investigational drug from a new class of molecules called Selective Androgen Receptor…NCT02499497·Gainesville, Florida and 3 others

TerminatedStudy of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsAt the time of study termination, NUV-422-02 was a first-in-human, open-label, Phase 1 dose escalation study designed to evaluate the safety and efficacy of NUV-422.NCT04541225·Tucson, Arizona and 11 others

Active not recruitingProstate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate CancerBackground: People with prostate cancer usually have their cancer imaged with a CT scan and bone scan. They then have their prostate gland removed.NCT03976843·New Orleans, Louisiana and 5 others

Not yet recruitingPRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear MicroscopyThis study will evaluate the use of intraoperative nonlinear microscopy (NLM) for surgical margin assessment during nerve-sparing radical prostatectomy in participants with…NCT07516808·Boston, Massachusetts

CompletedPROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyPROSTVAC-VF is an investigational cancer vaccine.NCT00078585·Homewood, Alabama and 46 others

Active not recruitingNivolumab in Patients With High-Risk Biochemically Recurrent Prostate CancerThis research study is studying an immune-based cancer drug as a possible treatment for prostate cancer. The drug involved in this study is: -NivolumabNCT03637543·Boston, Massachusetts and 4 others

CompletedA Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerThe purpose of this study is to determine the benefit of enzalutamide versus placebo as assessed by overall survival and progression-free survival in patients with progressive…NCT01212991·Birmingham, Alabama and 268 others

TerminatedStudy to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid TumorsThe goal of this interventional clinical trial is to learn about TNG348, a ubiquitin specific peptidase 1 (USP1) inhibitor, alone and in combination with olaparib in patients with…NCT06065059·Denver, Colorado and 6 others

CompletedS9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate CancerRATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00004124·Anchorage, Alaska and 233 others

CompletedImproving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health InterventionThis study evaluates a smart phone based mobile application designed for patients with Renal Cell and Prostate Cancer taking oral anti-cancer medications.NCT02375776·Boston, Massachusetts

Active not recruitingLuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate CancerThe purpose of this study is to see whether the combination of a chemotherapy drug, carboplatin, along with the radioligand treatment, 177Lu-PSMA-617, is safe in treating prostate…NCT06303713·Boston, Massachusetts and 2 others

CompletedStudy of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate CancerThe primary objective of this study was to compare the two alternate primary endpoints of radiographic progression-free survival (rPFS) and overall survival (OS) in patients with…NCT03511664·Scottsdale, Arizona and 87 others

CompletedNitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005820·Birmingham, Alabama and 49 others

CompletedRadiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases.NCT00003162·Birmingham, Alabama and 252 others

CompletedRadiation Therapy in Treating Patients With Stage II Prostate CancerRATIONALE: Giving radiation therapy that uses a 3-dimensional (3-D) image of the tumor to help focus thin beams of radiation directly on the tumor, and giving hypofractionated…NCT00331773·Phoenix, Arizona and 295 others

PreviousPage 10 of 26Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma